CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
6 research outputs found
Characterization of duvelisib in patients with refractory marginal zone lymphoma : data from the phase 2 DYNAMO trial
Author
Ardeshna Kirit
Bijou Fontanet
+13 more
Cherry Mohamad
Duras Juraj
Jacobsen Eric
Lustgarten Stephanie
Marasca Roberto
Mayer Jiri
Merli Michele
Musuraca Gerardo
Offner Fritz
Tani Monica
Weaver David
Youssoufian Hagop
Zinzani Pier Luigi
Publication venue
'Elsevier BV'
Publication date
01/01/2019
Field of study
No full text
Ghent University Academic Bibliography
P023: PET2-adapted approach after 2 cycles of ABVD is comparable to 2 cycles of BEACOPP escalated and 2 cycles of ABVD and irradiation in early unfavorable Hodgkin lymphoma
Author
Alice Sýkorová
David Belada
+8 more
Heidi Mocikova
Jana Markova
Juraj Duras
Lubica Gaherova
Maria Maco
Marie Lukášová
Tomas Kozak
Vit Prochazka
Publication venue
Wiley
Publication date
01/10/2022
Field of study
No full text
Directory of Open Access Journals
PubMed Central
Venetoclax plus bortezomib and dexamethasone in heavily pretreated end‐stage myeloma patients without t(11;14): A real‐world cohort
Author
Hana Plonkova
Jana Mihalyova
+9 more
Juraj Duras
Katerina Benkova
Lucie Cerna
Michal Kascak
Michal Simicek
Roman Hajek
Tereza Popkova
Tomas Jelinek
Zdenek Koristek
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Population-Based Analysis of Elderly Patients (>70 YEARS) with Peripheral T-CELL Lymphoma: A Results from Czech Lymphoma Study Group (CLSG) Registry
Author
Andrea Janikova
David Belada
+13 more
Heidi Mocikova
Jan Pirnos
Jiri Mayer
Juraj Duras
Katerina Benesova
Marek Trneny
Michaela Hamouzova
Natasa Kopalova
Pavel Klener
Robert Pytlik
Vit Campr
Vit Prochazka
Zbynek Bortlicek
Publication venue
'American Society of Hematology'
Publication date
Field of study
No full text
Crossref
Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy?
Author
Ahmed N
Andrea Janikova
+21 more
Armitage JO
Carbone PP
David Belada
Engelhard M
Finke J
Heidi Mocikova
Jan Pirnos
Jiri Mayer
Juraj Duras
Katerina Benesova
MacManus MP
Marek Trneny
Natasa Kopalova
Petersen PM
Poetsch M
Robert Pytlik
Samuel Vokurka
Sykorova A
Vit Campr
Vit Prochazka
Zbynek Bortlicek
Publication venue
'Informa UK Limited'
Publication date
Field of study
No full text
Crossref
Cytarabine + G-CSF is more effective than cyclophosphamide + G-CSF as a stem cell mobilization regimen in multiple myeloma
Author
B Barlogie
Chong Chyn Chua
+45 more
D Sheppard
Dana Salounova
E Jantunen
F Gay
FM Gay
H Kantarjian
Hana Plonkova
I Pusic
Ivana Tvrda
J Mihalyova
Jana Mihalyova
Jana Smejkalova
JR Passweg
Juraj Duras
KR Desikan
L Rasche
Laurent Garderet
Lucie Adamusova
M Attal
M Attal
M Cavo
M Cavo
M Mohty
M Montillo
M Sant
MA Gertz
Michal Kascak
Michal Simicek
Milan Navratil
O Fitoussi
P Moreau
R Silvennoinen
Roman Hajek
S D’Sa
S Giebel
S Giralt
SV Rajkumar
T Jelinek
T Jelinek
T Jelinek
Tereza Popkova
Tomas Jelinek
U Narayanasami
U Popat
Zdenek Koristek
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref